NCT00103142View on ClinicalTrials.gov

Vaccine Therapy in Treating Patients With Liver or Lung Metastases From Colorectal Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

74

Participants

Timeline

Start Date

February 28, 2005

Primary Completion Date

June 30, 2009

Study Completion Date

March 31, 2013

Conditions
Colorectal CancerMetastatic Cancer
Interventions
BIOLOGICAL

falimarev

Given subcutaneously and intradermally

BIOLOGICAL

inalimarev

Given subcutaneously and intradermally

BIOLOGICAL

sargramostim

Given subcutaneously

BIOLOGICAL

therapeutic autologous dendritic cells

Given subcutaneously and intradermally

Trial Locations (6)

20007

Lombardi Comprehensive Cancer Center at Georgetown University Medical Center, Washington D.C.

27157

Wake Forest University Baptist Medical Center, Winston-Salem

27710

Duke Comprehensive Cancer Center, Durham

29425

Hollings Cancer Center at Medical University of South Carolina, Charleston

33612-9497

H. Lee Moffitt Cancer Center and Research Institute at University of South Florida, Tampa

97213-2967

Providence Cancer Center at Providence Portland Medical Center, Portland

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Michael Morse, MD

OTHER

NCT00103142 - Vaccine Therapy in Treating Patients With Liver or Lung Metastases From Colorectal Cancer | Biotech Hunter | Biotech Hunter